These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
374 related items for PubMed ID: 17173349
41. Cervical cancer and prevention by vaccination: results from recent trials. Tjalma WA. Ann Oncol; 2006 Sep; 17 Suppl 10():x217-23. PubMed ID: 17018727 [No Abstract] [Full Text] [Related]
42. HPV vaccines--why aren't they the answer yet? Brown AK, Moore RG. Med Health R I; 2005 Mar; 88(3):74-9. PubMed ID: 15915778 [No Abstract] [Full Text] [Related]
43. Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination. Franco EL, Ferenczy A. Future Oncol; 2007 Jun; 3(3):319-27. PubMed ID: 17547527 [Abstract] [Full Text] [Related]
44. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs. Khan K, Curtis CR, Ekwueme DU, Stokley S, Walker C, Roland K, Benard V, Saraiya M. Cancer; 2008 Nov 15; 113(10 Suppl):3004-12. PubMed ID: 18980296 [Abstract] [Full Text] [Related]
45. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes... Prescrire Int; 2007 Jun 15; 16(89):91-4. PubMed ID: 17582921 [Abstract] [Full Text] [Related]
47. [Condyloma typing important for follow up of HPV vaccination. A condyloma reporting project]. Sturegård E, Johnsson A, Gustafsson E, Dillner J. Lakartidningen; 2007 Jun 15; 105(50):3648-50. PubMed ID: 19177930 [No Abstract] [Full Text] [Related]
49. Human papillomavirus, cervical cancer prevention, and more. Lowy D. Vaccine; 2008 Aug 19; 26 Suppl 10():iii-iv. PubMed ID: 18847562 [No Abstract] [Full Text] [Related]
50. [Advisory report from the Health Council of the Netherlands to include human papillomavirus vaccination in the national immunisation programme for the prevention of cervical cancer]. Boeke AJ. Ned Tijdschr Geneeskd; 2008 Apr 26; 152(17):981-3. PubMed ID: 18549170 [Abstract] [Full Text] [Related]
51. Three provinces to study 2-dose HPV vaccine. Eggertson L. CMAJ; 2007 Aug 28; 177(5):444-5. PubMed ID: 17724315 [No Abstract] [Full Text] [Related]
52. Latin America. Price is the main barrier to wider use of papillomavirus vaccine. Kaiser J. Science; 2008 May 16; 320(5878):860. PubMed ID: 18487164 [No Abstract] [Full Text] [Related]
53. [Resolution of the HPV Vaccine Working Group of December 12, 2006]. Vonka V, Hamsíková E, HPV Vaccine Working Group. Epidemiol Mikrobiol Imunol; 2007 Apr 16; 56(2):94-8. PubMed ID: 17593807 [No Abstract] [Full Text] [Related]
54. Prophylactic vaccines for human papillomavirus: a bright future for cervical cancer prevention. Szarewski A. J Med Screen; 2005 Apr 16; 12(4):163-5. PubMed ID: 16417690 [No Abstract] [Full Text] [Related]
59. Human papillomavirus and cervical disease in adolescents. Guido R. Clin Obstet Gynecol; 2008 Jun 16; 51(2):290-305. PubMed ID: 18463460 [Abstract] [Full Text] [Related]
60. Human papillomavirus, vaccines and women's health: questions and cautions. Lippman A, Melnychuk R, Shimmin C, Boscoe M. CMAJ; 2007 Aug 28; 177(5):484-7. PubMed ID: 17671239 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]